Jiangsu Gdk Biological Technology 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

Optimistic Investors Push Jiangsu Gdk Biological Technology Co., Ltd (SHSE:688670) Shares Up 25% But Growth Is Lacking

Mar 08

CEO

Jiangsu Gdk Biological Technology 에는 CEO가 없거나 그에 대한 데이터가 없습니다.

Jiangsu Gdk Biological Technology 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Jiangsu Gdk Biological Technology Co., Ltd, Annual General Meeting, May 08, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: CN¥0.10 loss per share (vs CN¥0.39 loss in 3Q 2023)

Jiangsu Gdk Biological Technology Co., Ltd to Report Q3, 2024 Results on Oct 25, 2024

New minor risk - Share price stability

Second quarter 2024 earnings released: CN¥0.16 loss per share (vs CN¥0.01 loss in 2Q 2023)

Jiangsu Gdk Biological Technology Co., Ltd to Report First Half, 2024 Results on Aug 21, 2024

First quarter 2024 earnings released: CN¥0.17 loss per share (vs CN¥0.29 profit in 1Q 2023)

Jiangsu Gdk Biological Technology Co., Ltd, Annual General Meeting, May 08, 2024

Jiangsu Gdk Biological Technology Co., Ltd to Report Q1, 2024 Results on Apr 16, 2024

Optimistic Investors Push Jiangsu Gdk Biological Technology Co., Ltd (SHSE:688670) Shares Up 25% But Growth Is Lacking

Less than half of directors are independent

New minor risk - Share price stability

Third quarter 2023 earnings released: CN¥0.39 loss per share (vs CN¥0.56 profit in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.01 loss per share (vs CN¥0.12 loss in 2Q 2022)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Jiangsu gdk Biotechnology Co., Ltd. to Report First Half, 2023 Results on Aug 03, 2023

Investor sentiment improves as stock rises 15%

First quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.03 loss in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.48 (vs CN¥1.10 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.79 (vs CN¥1.55 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

CEO